Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon J Baumgart

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
International Journal of Molecular Sciences|May 10, 2017
Exploiting Epigenetic Alterations in Prostate CancerSimon J Baumgart, Bernard Haendler
International Journal of Molecular Sciences|May 9, 2018
Recent Advances in Prostate Cancer Treatment and Drug DiscoveryEkaterina Nevedomskaya, Simon J Baumgart, Bernard Haendler
International Journal of Molecular Sciences|June 16, 2019
Dysregulated Transcriptional Control in Prostate CancerSimon J Baumgart, Ekaterina Nevedomskaya, Bernard Haendler
Bioinformatics (Oxford, England)|December 22, 2021
MACA: marker-based automatic cell-type annotation for single-cell expression dataYang Xu, Simon J Baumgart, Christian M Stegmann, et al.
Molecular Oncology|April 26, 2020
Darolutamide antagonizes androgen signaling by blocking enhancer and super-enhancer activationSimon J Baumgart, Ekaterina Nevedomskaya, Ralf Lesche, et al.
Cancers|January 8, 2023
Comparative Proteomic and Transcriptomic Analysis of the Impact of Androgen Stimulation and Darolutamide InhibitionEkaterina Nevedomskaya, Tatsuo Sugawara, Simon J Baumgart, et al.
International Journal of Cancer|March 5, 2019
Darolutamide is a potent androgen receptor antagonist with strong efficacy in prostate cancer modelsTatsuo Sugawara, Simon J Baumgart, Ekaterina Nevedomskaya, et al.
Cells|May 28, 2022
Fibrotic Signaling in Cardiac Fibroblasts and Vascular Smooth Muscle Cells: The Dual Roles of Fibrosis in HFpEF and CADJulian C Bachmann, Simon J Baumgart, Anna K Uryga, et al.
Nucleic Acids Research|May 6, 2017
CHD1 regulates cell fate determination by activation of differentiation-induced genesSimon J Baumgart, Zeynab Najafova, Tareq Hossan, et al.
EMBO Reports|September 7, 2016
Loss of CHD1 causes DNA repair defects and enhances prostate cancer therapeutic responsivenessVijayalakshmi Kari, Wael Yassin Mansour, Sanjay Kumar Raul, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
International Journal of Molecular Sciences|May 10, 2017
Exploiting Epigenetic Alterations in Prostate CancerSimon J Baumgart, Bernard Haendler
International Journal of Molecular Sciences|May 9, 2018
Recent Advances in Prostate Cancer Treatment and Drug DiscoveryEkaterina Nevedomskaya, Simon J Baumgart, Bernard Haendler
International Journal of Molecular Sciences|June 16, 2019
Dysregulated Transcriptional Control in Prostate CancerSimon J Baumgart, Ekaterina Nevedomskaya, Bernard Haendler
Bioinformatics (Oxford, England)|December 22, 2021
MACA: marker-based automatic cell-type annotation for single-cell expression dataYang Xu, Simon J Baumgart, Christian M Stegmann, et al.
Molecular Oncology|April 26, 2020
Darolutamide antagonizes androgen signaling by blocking enhancer and super-enhancer activationSimon J Baumgart, Ekaterina Nevedomskaya, Ralf Lesche, et al.
Cancers|January 8, 2023
Comparative Proteomic and Transcriptomic Analysis of the Impact of Androgen Stimulation and Darolutamide InhibitionEkaterina Nevedomskaya, Tatsuo Sugawara, Simon J Baumgart, et al.
International Journal of Cancer|March 5, 2019
Darolutamide is a potent androgen receptor antagonist with strong efficacy in prostate cancer modelsTatsuo Sugawara, Simon J Baumgart, Ekaterina Nevedomskaya, et al.
Cells|May 28, 2022
Fibrotic Signaling in Cardiac Fibroblasts and Vascular Smooth Muscle Cells: The Dual Roles of Fibrosis in HFpEF and CADJulian C Bachmann, Simon J Baumgart, Anna K Uryga, et al.
Nucleic Acids Research|May 6, 2017
CHD1 regulates cell fate determination by activation of differentiation-induced genesSimon J Baumgart, Zeynab Najafova, Tareq Hossan, et al.
EMBO Reports|September 7, 2016
Loss of CHD1 causes DNA repair defects and enhances prostate cancer therapeutic responsivenessVijayalakshmi Kari, Wael Yassin Mansour, Sanjay Kumar Raul, et al.
Pageof 2